The American journal on addictions
-
Despite the benefits of maintenance buprenorphine treatment for opioid use disorder (OUD), many individuals report an interest in discontinuing the medication, while also expressing worries about tapering. The purpose of this study was to develop a measure of worries about buprenorphine discontinuation ("Off Bupe") and determine the demographic and clinical characteristics associated with these worries. ⋯ The scale might help individuals with OUD and their providers identify concerns about discontinuing buprenorphine. (Am J Addict 2019;28:270-276).
-
Case Reports
Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series.
Buprenorphine/naloxone has been shown to be effective in the treatment of opioid use disorder. Due to its pharmacological properties, induction can be challenging, time-consuming, and result in sudden onset of withdrawal symptoms. ⋯ This method can be used to minimize barriers to opioid agonist therapy. (Am J Addict 2019;28:262-265).